0001567619-18-003956.txt : 20181010
0001567619-18-003956.hdr.sgml : 20181010
20181010194023
ACCESSION NUMBER: 0001567619-18-003956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181009
FILED AS OF DATE: 20181010
DATE AS OF CHANGE: 20181010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewicki John A.
CENTRAL INDEX KEY: 0001553352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 181117085
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2018-10-09
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001553352
Lewicki John A.
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
1
1
0
0
President & CEO
Common Stock
2018-10-09
4
S
0
2296
2.1289
D
57122
D
Common Stock
99388
I
See Footnote
Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock units ("RSU") award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
This transaction was executed in multiple trades in prices ranging from $2.1082 to $2.1289, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 39,375 RSUs. The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
Includes 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2018 and 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2018.
The shares are held by John Allan Lewicki and Jenniffer Joan Lewicki, Trustees of the Lewicki Family Trust dated December 6, 2000.
/s/ Alicia J. Hager, Attorney-in-Fact for John A. Lewicki
2018-10-10